The stock of Sera Prognostics Inc (NASDAQ: SERA) has decreased by -10.78 when compared to last closing price of 11.69.Despite this, the company has seen a gain of 3.88% in its stock price over the last five trading days. PRNewsWire reported 2024-04-29 that SALT LAKE CITY, April 29, 2024 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report first quarter fiscal year 2024 financial results on Wednesday, May 8, 2024, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m.
Is It Worth Investing in Sera Prognostics Inc (NASDAQ: SERA) Right Now?
Company’s 36-month beta value is 1.34.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SERA is 17.86M, and currently, short sellers hold a 1.31% ratio of that floaft. The average trading volume of SERA on May 02, 2024 was 205.82K shares.
SERA’s Market Performance
SERA stock saw an increase of 3.88% in the past week, with a monthly gain of 13.25% and a quarterly increase of 49.00%. The volatility ratio for the week is 10.01%, and the volatility levels for the last 30 days are 7.53% for Sera Prognostics Inc (SERA). The simple moving average for the past 20 days is 3.59% for SERA’s stock, with a 107.06% simple moving average for the past 200 days.
Analysts’ Opinion of SERA
Many brokerage firms have already submitted their reports for SERA stocks, with Citigroup repeating the rating for SERA by listing it as a “Neutral.” The predicted price for SERA in the upcoming period, according to Citigroup is $4 based on the research report published on March 30, 2022 of the previous year 2022.
Oppenheimer, on the other hand, stated in their research note that they expect to see SERA reach a price target of $19. The rating they have provided for SERA stocks is “Outperform” according to the report published on November 19th, 2021.
SERA Trading at 9.59% from the 50-Day Moving Average
After a stumble in the market that brought SERA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.76% of loss for the given period.
Volatility was left at 7.53%, however, over the last 30 days, the volatility rate increased by 10.01%, as shares surge +10.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +12.27% upper at present.
During the last 5 trading sessions, SERA rose by +3.88%, which changed the moving average for the period of 200-days by +217.02% in comparison to the 20-day moving average, which settled at $10.12. In addition, Sera Prognostics Inc saw 74.41% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SERA starting from Boniface John J., who sale 24,474 shares at the price of $9.04 back on Mar 28 ’24. After this action, Boniface John J. now owns 139,771 shares of Sera Prognostics Inc, valued at $221,245 using the latest closing price.
Boniface John J., the Chief Scientific Officer of Sera Prognostics Inc, sale 52,662 shares at $9.62 during a trade that took place back on Mar 27 ’24, which means that Boniface John J. is holding 139,771 shares at $506,608 based on the most recent closing price.
Stock Fundamentals for SERA
Current profitability levels for the company are sitting at:
- -129.81 for the present operating margin
- -0.38 for the gross margin
The net margin for Sera Prognostics Inc stands at -115.99. The total capital return value is set at -0.56. Equity return is now at value -42.86, with -34.23 for asset returns.
Based on Sera Prognostics Inc (SERA), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -14.63. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -722.2.
Currently, EBITDA for the company is -38.62 million with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of 1072.97. The receivables turnover for the company is 0.03for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.51.
Conclusion
In a nutshell, Sera Prognostics Inc (SERA) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
